A research team has developed a multisite bridging-mediated lateral flow immunoassay (mbLFIA) that enables highly sensitive, ...
The tests are intended for infectious and chronic disease detection and diagnosis as well as to aid in routine health monitoring.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results